150
Participants
Start Date
June 30, 2016
Primary Completion Date
December 31, 2017
Study Completion Date
June 30, 2018
Sudoscan and clinical assessment
The primary variable will be electrochemical skin conductance (ESC), as assessed by the SudoScan (Impeto Medical, France). The clinical assessment will include a neurological evaluation (including MDS-UPDRS), evaluation of autonomic symptoms and signs, EKG, evaluation of possible neuropathy and evaluation of non-motor variables.
Skin biopsy
Evaluation of the denervation and synuclein deposition of skin biopsy
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER